12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

MorphiDex: Phase III data; NDA under review

ALGO presented updated results from its pivotal clinical trials of MorphiDex (see BioCentury, Sept. 21, 1998).

In a single-dose study of 535 oral surgery patients, MorphiDex produced pain relief superior to morphine alone, dextromethorphan alone and placebo (p<0.05 in all cases). MorphiDex had a pain relief onset of 1.5 hours versus 3 hours for...

Read the full 257 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >